相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of Magnetic Resonance Imaging in the Management of Esophageal Cancer
Anna Pellat et al.
CANCERS (2022)
A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trial
Eleanor M. Hudson et al.
BMJ OPEN (2022)
Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin Lymphoma
Simone de Vries et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Dose escalation based on 18F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)
Hongcheng Zhu et al.
RADIATION ONCOLOGY (2022)
Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System
Hyunjong Lee et al.
FRONTIERS IN ONCOLOGY (2022)
Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP
Ciara L. Freeman et al.
BLOOD (2021)
EANM/SNMMI practice guideline for [18F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0
Judit A. Adam et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Changes in treatment intent and target definition for preoperative radiotherapy after 18F-Fluorodeoxyglucose positron emission tomography in rectal cancer: A Meta-analysis
Soo Jin Lee et al.
EUROPEAN JOURNAL OF RADIOLOGY (2021)
Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer
Niels W. Schurink et al.
EUROPEAN RADIOLOGY (2021)
FDG-PET/CT in Lymphoma: Where Do We Go Now?
Yassine Al Tabaa et al.
CANCERS (2021)
OA02.05 Local, Regional and Pulmonary Failures in the Randomised PET-Boost Trial for NSCLC Patients
S. Cooke et al.
Journal of Thoracic Oncology (2021)
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
Richard Pötter et al.
LANCET ONCOLOGY (2021)
Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis
Claire Petit et al.
LANCET ONCOLOGY (2021)
Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial
C. Poettgen et al.
RADIATION ONCOLOGY (2021)
Updated protocol of the SANO trial: a stepped-wedge cluster randomised trial comparing surgery with active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer
Ben M. Eyck et al.
TRIALS (2021)
Review of MR-Guided Radiotherapy for Esophageal Cancer
Sangjune Laurence Lee et al.
FRONTIERS IN ONCOLOGY (2021)
LYMPHOMA: ADVANCES IN IMAGING AND RADIOTHERAPY SPECIAL FEATURE: COMMENTARY Progress and pitfalls with the use of image- guided personalised approaches in lymphoma
Tim M. Illidge et al.
BRITISH JOURNAL OF RADIOLOGY (2021)
LYMPHOMA: ADVANCES IN IMAGING AND RADIOTHERAPY SPECIAL FEATURE: REVIEW ARTICLE PET- guided treatment for personalised therapy of Hodgkin lymphoma and aggressive non- Hodgkin lymphoma
Elizabeth H. Phillips et al.
BRITISH JOURNAL OF RADIOLOGY (2021)
Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study)
Maarten C. C. M. Hulshof et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma
David J. Cutter et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapy
Zhigang Yuan et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2021)
Local and regional treatment response by 18FDG-PET-CT-scans 4 weeks after concurrent hypofractionated chemoradiotherapy in locally advanced NSCLC
Judi N. A. van Diessen et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Prognostic utility of serial 18F-FDG-PET/CT in patients with locally advanced rectal cancer who underwent tri-modality treatment
Sumal Fernando et al.
BRITISH JOURNAL OF RADIOLOGY (2020)
Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis
Sungmin Woo et al.
EUROPEAN RADIOLOGY (2020)
Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer
Zeno A. R. Gouw et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Parametric Response Mapping of Coregistered Positron Emission Tomography and Dynamic Contrast Enhanced Computed Tomography to Identify Radioresistant Subvolumes in Locally Advanced Cervical Cancer
Dante P. Capaldi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial
Ursula Nestle et al.
LANCET ONCOLOGY (2020)
Advances in cancer imaging require renewed radiotherapy dose and target volume concepts
Johannes H. A. M. Kaanders et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
Andrea Gallamini et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy
Nicola Simoni et al.
FRONTIERS IN ONCOLOGY (2020)
Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma
Tim M. Illidge et al.
BLOOD ADVANCES (2020)
Is It Time to Introduce PET/CT in Rectal Cancer Guidelines?
Anna Margherita Maffione et al.
CLINICAL NUCLEAR MEDICINE (2020)
Accuracy of 18F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer
Maria J. Valkema et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
18F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer
Antonio Avallone et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Quantitative analysis of 18-FDG-PET/MRI to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. A prospective preliminary study
Valentina Ferri et al.
ACTA ONCOLOGICA (2019)
PET-DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL)
M. Balzarotti et al.
HEMATOLOGICAL ONCOLOGY (2019)
Molecular Imaging for Radiotherapy Planning and Response Assessment for Cervical Cancer
Alexander J. Lin et al.
SEMINARS IN NUCLEAR MEDICINE (2019)
Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group
Michael Fuchs et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features
V. Giannini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial)
Judi van Diessen et al.
RADIOTHERAPY AND ONCOLOGY (2019)
DW-MRI and DCE-MRI are of complementary value in predicting pathologic response to neoadjuvant chemoradiotherapy for esophageal cancer
Sophie E. Heethuis et al.
ACTA ONCOLOGICA (2018)
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial
Ulrich Duehrsen et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study
Bo Jan Noordman et al.
LANCET ONCOLOGY (2018)
Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: Radiotherapy target volume transformation and dose de-escalation
Sven van den Bosch et al.
RADIOTHERAPY AND ONCOLOGY (2018)
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer
Ursula Nestle et al.
RADIOTHERAPY AND ONCOLOGY (2018)
The Role of PET-Based Radiomic Features in Predicting Local Control of Esophageal Cancer Treated with Concurrent Chemoradiotherapy
Junfeng Xiong et al.
SCIENTIFIC REPORTS (2018)
Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study
A. S. Borggreve et al.
BMC CANCER (2018)
Targeting glucose and glutamine metabolism combined with radiation therapy in non-small cell lung cancer
Tineke W. H. Meijer et al.
LUNG CANCER (2018)
Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring 18F-FDG-PET/CT
Tineke W. H. Meijer et al.
PHYSICS & IMAGING IN RADIATION ONCOLOGY (2018)
FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
Sally F. Barrington et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Long-term outcome of 18F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study
Dieter Berwouts et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
Interim 18F-FDG PET/CT During Chemoradiation Therapy in the Management of Head and Neck Cancer Patients: A Systematic Review
Cristina Garibaldi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial
Marc P. E. Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma
Sven van den Bosch et al.
BMC CANCER (2017)
Prognostic utility of diffusion-weighted MRI in oesophageal cancer: is apparent diffusion coefficient a potential marker of tumour aggressiveness?
Francesco Giganti et al.
RADIOLOGIA MEDICA (2016)
Patterns of failure after use of 18F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases
Yih-Lin Chung et al.
BMC CANCER (2016)
FDG PET/CT Can Assess the Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy: Evidence From Meta-analysis and Systematic Review
Ben Rymer et al.
CLINICAL NUCLEAR MEDICINE (2016)
Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma
Sven van den Bosch et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin's Lymphoma
Peter Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Short-course PET based simultaneous integrated boost for locally advanced cervical cancer
Marius Rothe Arnesen et al.
RADIATION ONCOLOGY (2016)
Positron emission tomography/computerized tomography for tumor response assessment-a review of clinical practices and radiomics studies
Wei Lu et al.
TRANSLATIONAL CANCER RESEARCH (2016)
Impact of radiation dose and standardized uptake value of (18) FDG PET on nodal control in locally advanced cervical cancer
Anne Ramlov et al.
ACTA ONCOLOGICA (2015)
Effectiveness of Neoadjuvant Chemoradiotherapy for Early-Stage Esophageal Cancer
Joel Shapiro et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro et al.
LANCET ONCOLOGY (2015)
Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin's Lymphoma
John Radford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by 18FDG-PET/CT for esophageal cancer
Wen Yu et al.
RADIOTHERAPY AND ONCOLOGY (2015)
FDG-PET/CT during concomitant chemo radiotherapy for esophageal cancer: Reducing target volumes to deliver higher radiotherapy doses
Lamyaa Nkhali et al.
ACTA ONCOLOGICA (2015)
Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes
Michaela K. Keck et al.
CLINICAL CANCER RESEARCH (2015)
Textural Parameters of Tumor Heterogeneity in 18F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer
Ralph A. Bundschuh et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma
Olga C. J. Schuurbiers et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
The role of diffusion-weighted MRI and 18F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: A systematic review
Ines Joye et al.
RADIOTHERAPY AND ONCOLOGY (2014)
18F-FDG PET Early Response Evaluation of Locally Advanced Non-Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy
Edwin A. Usmanij et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Three-phase adaptive dose-painting-by-numbers for head-and-neck cancer: initial results of the phase I clinical trial
Dieter Berwouts et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy
Tineke W. H. Meijer et al.
CLINICAL CANCER RESEARCH (2012)
Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4
Tineke W. H. Meijer et al.
LUNG CANCER (2012)
Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
Patsuree Cheebsumon et al.
EJNMMI RESEARCH (2012)
ADAPTIVE DOSE PAINTING BY NUMBERS FOR HEAD-AND-NECK CANCER
Frederic Duprez et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP
Keiichi Jingu et al.
BMC CANCER (2010)
STEREOTACTIC ABLATIVE RADIOTHERAPY SHOULD BE COMBINED WITH A HYPOXIC CELL RADIOSENSITIZER
J. Martin Brown et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
FDG for dose painting: A rational choice
Hugo J. W. L. Aerts et al.
RADIOTHERAPY AND ONCOLOGY (2010)
18F-Fluorodeoxiglucose Positron Emission Tomography for the Evaluation of Neoadjuvant Therapy Response in Esophageal Cancer Systematic Review of the Literature
Angel C. Rebollo Aguirre et al.
ANNALS OF SURGERY (2009)
Serial FDG-PET on patients with head and neck cancer: Implications for radiation therapy
Maria Hentschel et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2009)
PROSPECTIVE CLINICAL TRIAL OF POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IMAGE-GUIDED INTENSITY-MODULATED RADIATION THERAPY FOR CERVICAL CARCINOMA WITH POSITIVE PARA-AORTIC LYMPH NODES
Jacqueline Esthappan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer
Indira Madani et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer
Joseph G. Rajendran et al.
CLINICAL CANCER RESEARCH (2006)
Clinical prediction model to characterize pulmonary nodules -: Validation and added value of 18F-fluorodeoxyglucose positron emission tomography
GJ Herder et al.
CHEST (2005)
Theragnostic imaging for radiation oncology: dose-painting by numbers
SM Bentzen
LANCET ONCOLOGY (2005)
Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers
J Bussink et al.
RADIOTHERAPY AND ONCOLOGY (2003)
Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer
KSC Chao et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality
CC Ling et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer
LA Dawson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
分享论文
